162 related articles for article (PubMed ID: 10516443)
1. Factors influencing the course of calcium oxalate stone disease.
Tiselius HG
Eur Urol; 1999 Nov; 36(5):363-70. PubMed ID: 10516443
[TBL] [Abstract][Full Text] [Related]
2. How are urine composition and stone disease affected by therapeutic measures at an outpatient stone clinic?
Tiselius HG; Sandvall K
Eur Urol; 1990; 17(3):206-12. PubMed ID: 2351189
[TBL] [Abstract][Full Text] [Related]
3. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
[TBL] [Abstract][Full Text] [Related]
4. Aspects on estimation of the risk of calcium oxalate crystallization in urine.
Tiselius HG
Urol Int; 1991; 47(4):255-9. PubMed ID: 1781112
[TBL] [Abstract][Full Text] [Related]
5. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
Murayama T; Taguchi H
Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of calcium stone formation in patients with primary Sjögren's syndrome.
Eriksson P; Denneberg T; Tiselius HG
Urol Res; 1996; 24(1):39-43. PubMed ID: 8966840
[TBL] [Abstract][Full Text] [Related]
7. Composition of Urine Collected from Non-Stone-Forming Chinese Persons during Different Short-Term Periods of the Day.
He Z; Chang Z; An L; Lei M; Jiang Z; Ou L; Wu W; Tiselius HG
Urol Int; 2022; 106(3):227-234. PubMed ID: 33744905
[TBL] [Abstract][Full Text] [Related]
8. Effect of sample time on urinary lithogenic risk indexes in healthy and stone-forming adults and children.
Rodriguez A; Saez-Torres C; Mir C; Casasayas P; Rodriguez N; Rodrigo D; Frontera G; Buades JM; Gomez C; Costa-Bauza A; Grases F
BMC Urol; 2018 Dec; 18(1):116. PubMed ID: 30567525
[TBL] [Abstract][Full Text] [Related]
9. Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients.
Siener R; Glatz S; Nicolay C; Hesse A
Eur Urol; 2003 Oct; 44(4):467-74. PubMed ID: 14499683
[TBL] [Abstract][Full Text] [Related]
10. Risk of Chronic Kidney Disease in Brushite Stone Formers Compared With Idiopathic Calcium Oxalate Stone Formers.
Rivera M; Jaeger C; Yelfimov D; Krambeck AE
Urology; 2017 Jan; 99():23-26. PubMed ID: 27634734
[TBL] [Abstract][Full Text] [Related]
11. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.
Tiselius HG
Clin Chim Acta; 1982 Jul; 122(3):409-18. PubMed ID: 7105424
[TBL] [Abstract][Full Text] [Related]
12. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
13. Alkaline citrate in prevention of recurrent calcium oxalate stones.
Berg C
Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
[TBL] [Abstract][Full Text] [Related]
14. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
[TBL] [Abstract][Full Text] [Related]
15. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
[TBL] [Abstract][Full Text] [Related]
16. Standardized estimate of the ion activity product of calcium oxalate in urine from renal stone formers.
Tiselius HG
Eur Urol; 1989; 16(1):48-50. PubMed ID: 2714318
[TBL] [Abstract][Full Text] [Related]
17. Urolithiasis in geriatric patients.
Usui Y; Matsuzaki S; Matsushita K; Shima M
Tokai J Exp Clin Med; 2003 Jul; 28(2):81-7. PubMed ID: 14714833
[TBL] [Abstract][Full Text] [Related]
18. Stone formation and urine composition in calcium stone formers without medical treatment.
Bek-Jensen H; Tiselius HG
Eur Urol; 1989; 16(2):144-50. PubMed ID: 2714332
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
[TBL] [Abstract][Full Text] [Related]
20. Stone recurrence predictive score (SRPS) for patients with calcium oxalate stones.
Lee YH; Huang WC; Lu CM; Tsai JY; Huang JK
J Urol; 2003 Aug; 170(2 Pt 1):404-7. PubMed ID: 12853786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
